Skip to main content
. 2021 Nov 2;11(11):2027. doi: 10.3390/diagnostics11112027

Figure 1.

Figure 1

Distribution of DABI, RIVA, and API levels before (left blue) and after (right orange) DOAC procedure performed by dTT/anti-Xa (functional assays, FA) and LC-MS with the aforementioned fold changes (FC). Abbreviations: DABI, dabigatran; RIVA, rivaroxaban; API, apixaban; FA, functional assay.